Vitamin D status can affect COVID-19 outcomes also in pediatric population

Autor: Michele Miraglia del Giudice, Cristiana Indolfi, Giulio Dinardo, Fabio Decimo, Alberto Decimo, Angela Klain
Přispěvatelé: Miraglia Del Giudice, Michele, Indolfi, Cristiana, Dinardo, Giulio, Decimo, Fabio, Decimo, Alberto, Klain, Angela
Rok vydání: 2022
Předmět:
Zdroj: PharmaNutrition. 22:100319
ISSN: 2213-4344
DOI: 10.1016/j.phanu.2022.100319
Popis: Background: vitamin D influences the immune system and the inflammatory response. It is known that vitamin D supplementation reduces the risk of acute respiratory tract infection. In the last two years, many researchers have investigated vitamin D's role in the pathophysiology of COVID-19 disease. Results: the findings obtained from clinical trials and systematic reviews highlight that most patients with COVID19 have decreased vitamin D levels and low levels of vitamin D increase the risk of severe disease. This evidence seems to be also confirmed in the pediatric population. Conclusions: further studies (systematic review and meta-analysis) conducted on children are needed to confirm that vitamin D affects COVID-19 outcomes and to determine the effectiveness of supplementation and the appropriate dose, duration and mode of administration.
Databáze: OpenAIRE